Johns Hopkins JCI Board Completes Five-Year Term

This June marks five years since the Journal of Clinical Investigation (JCI) came to Johns Hopkins. The JCI is the leading physician scientist journal established in 1924 for the American Society of Clinical Investigation (ASCI). It moves home institutions and elects a new editorial board every five years. While the journal originated at Johns Hopkins, this was the first time the editorial board was housed here. Dr. Rex Ahima, professor and director of the Division of Endocrinology, Diabetes & Metabolism has served as editor-in-chief for the past four years. During his tenure, the journal's impact factor rose from 11.864 (2019) to 14.808 (2020).

Read Dr. Ahima's farewell editorial here.

The distinguished editorial board of Johns Hopkins faculty members serving as JCI associate editors includes Richard F. Ambinder, MD, PhD (oncology), Mark E. Anderson, MD, PhD (cardiology), Mary Y. Armanios, MD (oncology, aging), William R. Bishai, MD, PhD (infectious disease), Robert A. Brodsky, MD (hematology), Peter A. Calabresi, MD (neuroinflammation), Thomas L. Clemens, PhD (bone biology), Franco R. D’Alessio, MD (pulmonology), Ted M. Dawson, MD, PhD (neuroscience), Angelo M. DeMarzo, MD, PhD (oncology), Stephen Desiderio, MD, PhD (immunology, cell biology), Harry C. Dietz III, MD (genetics), Mark Donowitz, MD (gastroenterology), Andrew P. Feinberg, MD, MPH (genetics), Sharon Gerecht, PhD (vascular biology, tissue engineering), Paul M. Hassoun, MD (pulmonology), Elizabeth M. Jaffe, MD (oncology, immunology), David A. Kass, MD (cardiology), Kieren A. Marr, MD (infectious disease, transplantation), Timothy H. Moran, PhD (metabolism and psychiatric disorders), William Nelson, MD, PhD (oncology), Brian O’Rourke, PhD (cardiology), Ben Ho Park, MD, PhD (oncology), Jonathan D. Powell, MD, PhD (immunology), Thomas C. Quinn, MD (infectious disease), Hamid Rabb, MD (nephrology), Stuart C. Ray, MD (infectious disease), Linda Resar, MD (hematology), Antony Rosen, MD (rheumatology), Jeffrey D. Rothstein, MD, PhD (neuroscience), Scheherazade Sadegh-Nasseri, PhD (immunology), Jonathan Schneck, MD, PhD (immunology), Gregg L. Semenza, MD, PhD (cell biology, signaling), Robert F. Siliciano, MD, PhD (infectious disease, HIV), Charlotte Sumner, MD (muscle biology), David L. Thomas, MD, MPH (infectious disease), and Robert G. Weiss, MD (cardiology, energetics).